The Valley Desk

ArticleCancer cellPublished

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

12 of 31 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Cancer cell
Published
Subject terms
Humans; Breast Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Neoadjuvant Therapy; Biology; Female; Triple Negative Breast Neoplasms; Circulating Tumor DNA; Clinical Relevance; Erb-b2 Receptor Tyrosine Kinases; receptor subtype; Neoadjuvant chemotherapy
PubMed ID
37146605
PubMed Central ID
PMC10330514
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal